These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34369813)
1. A robust ferroptosis-related gene signature predicts overall survival in clear cell renal cell carcinoma. Canxuan L; Dan L Future Oncol; 2021 Nov; 17(32):4321-4341. PubMed ID: 34369813 [TBL] [Abstract][Full Text] [Related]
2. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048 [TBL] [Abstract][Full Text] [Related]
3. A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma. Chen S; Zhang E; Guo T; Shao J; Wang T; Zhang N; Wang X; Zheng J BMC Cancer; 2022 Jan; 22(1):1. PubMed ID: 34979993 [TBL] [Abstract][Full Text] [Related]
4. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. Hong Y; Lin M; Ou D; Huang Z; Shen P BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma. Zheng B; Niu Z; Si S; Zhao G; Wang J; Yao Z; Cheng F; He W Aging (Albany NY); 2021 Aug; 13(15):19789-19804. PubMed ID: 34370716 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma. Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859 [TBL] [Abstract][Full Text] [Related]
7. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma. Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763 [TBL] [Abstract][Full Text] [Related]
8. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients. Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma. Lai J; Miao S; Ran L Sci Rep; 2023 Feb; 13(1):2114. PubMed ID: 36747047 [TBL] [Abstract][Full Text] [Related]
10. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model. Xiang X; Guo Y; Chen Z; Zhang F; Qin Y Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883 [TBL] [Abstract][Full Text] [Related]
11. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma. Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173 [TBL] [Abstract][Full Text] [Related]
12. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma. He Z; Deng T; Duan X; Zeng G Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. Ju L; Shi Y; Liu G PeerJ; 2022; 10():e14506. PubMed ID: 36570012 [TBL] [Abstract][Full Text] [Related]
14. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
15. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study. Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566 [TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma. Liu JW; Supandi F; Dhillon SK Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853 [TBL] [Abstract][Full Text] [Related]
17. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
18. Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma. Luo G; Wang L; Zheng Z; Gao B; Lei C Eur J Med Res; 2023 May; 28(1):176. PubMed ID: 37189176 [TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
20. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]